CASP3 and breast carcinoma: When applied to MDA-MB-231 and MDA-MB-436 breast cancer cells, P18 downregulated oncoproteins like p-Src and Snail, while simultaneously acting as a cytotoxic agent by increasing the levels of cleaved caspase 3, an apoptotic marker (Figure 4b).